Homepage
Author:
Sutro Biopharma, Inc.
Posted Date:
April 19, 2026
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
Sutro Biopharma, Inc.
April 19, 2026
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Sutro Biopharma, Inc.
March 24, 2026
Sutro Biopharma to Participate in Upcoming Investor Conferences
Sutro Biopharma, Inc.
February 25, 2026
Sutro Biopharma Announces Participation at the 16th World ADC London Summit
Sutro Biopharma, Inc.
February 23, 2026
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
Sutro Biopharma, Inc.
February 10, 2026
